PleoPharma, Inc

Headquarters

Boca Raton, FL

PleoPharma is a pharmaceutical company developing treatments for Cannabis Use Disorder (CUD) and Cannabis Withdrawal Syndrome (CWS). Their lead program, PP-01, is an oral prescription medication that has completed Phase 2 clinical trials.

• BraeburnBraeburn is a pharmaceutical company dedicated to transforming the management of opioid use disorder through next-generation therapies. The company focuses on developing and delivering solutions for people living with the serious consequences of opioid addiction, with a mission to advance individualized dosing regimens and delivery options.325412PLYMOUTH MEETING, PA
• Agronomed Pharmaceuticals LLCAgronomed Pharmaceuticals LLC is a premier cultivator, processor, and supplier of cannabis-based health products, committed to advancing the medical cannabis industry through research and development of targeted formulations. The company focuses on developing pharmaceutical products containing cannabis compounds for specific medical indications.EXTON, PA
• Neuropathix, IncNeuropathix, Inc. is a biopharmaceutical company focused on the research and development of a pipeline of next generation breakthrough therapeutics targeting inflammation to treat patients with significant unmet medical needs. The company's lead candidate is KLS-13019, a patented, non-opioid cannabinoid derivative for neuropathic pain.DOYLESTOWN, PA
• iCeuticaiCeutica is a pharmaceutical research and development company that applies its proprietary SoluMatrix Fine Particle Technology to create new branded medicines with improved efficacy, better side effect profiles, and more convenient dosing. The company works with pharmaceutical partners and advances its own pipeline of product candidates for pain and inflammation, oncology, and respiratory diseases.KING OF PRUSSIA, PA